Clinicopathological Characteristics of a Distinct Tumor Phenotype: Invasive Lobular Carcinoma With Tubular Elements in the West German Study Group ADAPTcycle Trial

Invasive lobular carcinoma with tubular elements (ILC-TE) is a recently identified variant of invasive lobular breast carcinoma (ILC). The histology of ILC-TE is defined by noncohesive carcinoma cells mixed with cohesive tubular elements and complete loss of epithelial (E)-cadherin. Cell-cell adhesion is partially restored by switching from an E-cadherin-deficient to a placental (P)-cadherin-proficient status (EPS). The prevalence of ILC-TE remains unknown. Here, we report data from the central pathology review of >4500 hormone receptor-positive/HER2-negative breast cancer (BC) cases recruited to the West German Study Group (WSG) ADAPTcycle trial (NCT04055493). The central pathology review included prospective assessment of BC types, variants, and E-cadherin expression. Cases classified as ILC-TE were analyzed for their molecular features and clinicopathological characteristics. Pure ILC with complete loss of E-cadherin accounted for 630 of 4619 (13.6%) BC cases. ILC-TE accounted for 47 of 630 (7.5%) lobular carcinomas, making it more than twice as prevalent as mixed BC (NST/ILC). ILC-TE harbored deleterious CDH1/E-cadherin mutations in 27 of 35 (77%) cases tested. EPS was detected in 43 of 47 (91%) ILC-TE cases. EPS was significantly more common in ILC-TE than in classic ILC or other ILC variants (P < .001). Clinically, ILC-TE was associated with cT1 stage (P = .023), cN0 status (P = .024), lower histologic grade (P = .004), and lower Ki67 (P = .012). In contrast, solid ILC was associated with higher Ki67 (P = .006). Following preoperative endocrine therapy, higher post-preoperative endocrine therapy Ki67 levels were observed in trabecular ILC, solid-papillary ILC, and pleomorphic ILC (P < .001, P = .006, and P = .021, respectively). In summary, ILC-TE is a quite common ILC variant that is associated with EPS, less-aggressive clinical features, and slow growth.

Authors

Institutions

Publication Details

Journal
Laboratory Investigation
Published
2025-03-05
DOI
https://doi.org/10.1016/j.labinv.2025.104125
Citations
2
Primary Topic
Gastrointestinal Tumor Research and Treatment
Type
article
Field-Weighted Citation Impact
3.62
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinicopathological Characteristics of a Distinct Tumor Phenotype: Invasive Lobular Carcinoma With Tubular Elements in the West German Study Group ADAPTcycle Trial

Nora Schaumann, Katarzyna Jóźwiak, Oleg Gluz, Stephan Bartels et al.
2 citations
Laboratory Investigation
Gastrointestinal Tumor Research and Treatment
3.62
article

Clinicopathological Characteristics of a Distinct Tumor Phenotype: Invasive Lobular Carcinoma With Tubular Elements in the West German Study Group ADAPTcycle Trial

Nora Schaumann, Katarzyna Jóźwiak, Oleg Gluz, Stephan Bartels, Matthias Christgen, Mieke Raap, Nadia Harbeck, Christine zu Eulenburg, Martin Radner, Malte Gronewold, Henriette Christgen, Sherko Kuemmel, Petra Hillmann, Hans Kreipe, Leonie Donata Kandt, Ulrich Lehmann, Sandy Burmeister, Monika Graeser
article en
2 citations

Abstract

Invasive lobular carcinoma with tubular elements (ILC-TE) is a recently identified variant of invasive lobular breast carcinoma (ILC). The histology of ILC-TE is defined by noncohesive carcinoma cells mixed with cohesive tubular elements and complete loss of epithelial (E)-cadherin. Cell-cell adhesion is partially restored by switching from an E-cadherin-deficient to a placental (P)-cadherin-proficient status (EPS). The prevalence of ILC-TE remains unknown. Here, we report data from the central pathology review of >4500 hormone receptor-positive/HER2-negative breast cancer (BC) cases recruited to the West German Study Group (WSG) ADAPTcycle trial (NCT04055493). The central pathology review included prospective assessment of BC types, variants, and E-cadherin expression. Cases classified as ILC-TE were analyzed for their molecular features and clinicopathological characteristics. Pure ILC with complete loss of E-cadherin accounted for 630 of 4619 (13.6%) BC cases. ILC-TE accounted for 47 of 630 (7.5%) lobular carcinomas, making it more than twice as prevalent as mixed BC (NST/ILC). ILC-TE harbored deleterious CDH1/E-cadherin mutations in 27 of 35 (77%) cases tested. EPS was detected in 43 of 47 (91%) ILC-TE cases. EPS was significantly more common in ILC-TE than in classic ILC or other ILC variants (P < .001). Clinically, ILC-TE was associated with cT1 stage (P = .023), cN0 status (P = .024), lower histologic grade (P = .004), and lower Ki67 (P = .012). In contrast, solid ILC was associated with higher Ki67 (P = .006). Following preoperative endocrine therapy, higher post-preoperative endocrine therapy Ki67 levels were observed in trabecular ILC, solid-papillary ILC, and pleomorphic ILC (P < .001, P = .006, and P = .021, respectively). In summary, ILC-TE is a quite common ILC variant that is associated with EPS, less-aggressive clinical features, and slow growth.

Laboratory InvestigationVol. 105(6)
Universität Hamburg (DE), Bethesda Hospital (IN), Deutsches Archäologisches Institut, Zentrale (DE), Medizinische Hochschule Hannover (DE), University Medical Center Hamburg-Eppendorf (DE), Breast Center (CH), Medizinische Hochschule Brandenburg Theodor Fontane (DE), Kliniken Essen-Mitte (DE), Ludwig-Maximilians-Universität München (DE)
Good health and well-being
Openalex Percentile: Top 10%
Gastrointestinal Tumor Research and Treatment
3.62
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.